Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Lifecare AS ( (DE:LFC0) ) just unveiled an update.
Lifecare ASA has completed the registration of a share capital increase tied to the issuance of 12,000,000 new shares as underwriting commission to the underwriters of its partially underwritten rights issue, bringing the company’s total share capital to NOK 19,106,097.30 divided into 191,060,973 shares. In addition, the company has registered a total of 18,000,000 warrants allocated to these underwriters, split equally between two series with separate exercise periods in March and June 2026, a step that finalizes key elements of the rights issue structure and may influence future dilution and capital flexibility for existing and prospective shareholders.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing technology for sensing and monitoring various body analytes, with a primary emphasis on next-generation continuous glucose monitoring (CGM) systems. Its osmotic pressure-based sensor technology is designed for use in both humans and pets and targets a broad range of analytes and molecules, positioning the company within the medtech and digital health markets.
Average Trading Volume: 755,142
Current Market Cap: NOK107.1M
Find detailed analytics on LFC0 stock on TipRanks’ Stock Analysis page.